- Home
- OFIX vs ABUS Comparison
OFIX vs ABUS Comparison
Compare OFIX & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OFIX
- ABUS
- Stock Information
- Founded
- OFIX 1987
- ABUS 2005
- Country
- OFIX United States
- ABUS United States
- Employees
- OFIX N/A
- ABUS N/A
- Industry
- OFIX Medical/Dental Instruments
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- OFIX Health Care
- ABUS Health Care
- Exchange
- OFIX Nasdaq
- ABUS Nasdaq
- Market Cap
- OFIX 648.7M
- ABUS 592.8M
- IPO Year
- OFIX N/A
- ABUS N/A
- Fundamental
- Price
- OFIX $12.11
- ABUS $3.23
- Analyst Decision
- OFIX Strong Buy
- ABUS Strong Buy
- Analyst Count
- OFIX 3
- ABUS 4
- Target Price
- OFIX $23.33
- ABUS $5.50
- AVG Volume (30 Days)
- OFIX 350.2K
- ABUS 872.9K
- Earning Date
- OFIX 05-06-2025
- ABUS 05-20-2025
- Dividend Yield
- OFIX N/A
- ABUS N/A
- EPS Growth
- OFIX N/A
- ABUS N/A
- EPS
- OFIX N/A
- ABUS N/A
- Revenue
- OFIX $804,529,000.00
- ABUS $6,171,000.00
- Revenue This Year
- OFIX $4.87
- ABUS $14.57
- Revenue Next Year
- OFIX $6.40
- ABUS $15.84
- P/E Ratio
- OFIX N/A
- ABUS N/A
- Revenue Growth
- OFIX 5.85
- ABUS N/A
- 52 Week Low
- OFIX $12.08
- ABUS $2.63
- 52 Week High
- OFIX $20.73
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- OFIX 30.25
- ABUS 45.18
- Support Level
- OFIX $11.85
- ABUS $3.11
- Resistance Level
- OFIX $14.26
- ABUS $3.73
- Average True Range (ATR)
- OFIX 0.65
- ABUS 0.16
- MACD
- OFIX -0.07
- ABUS -0.01
- Stochastic Oscillator
- OFIX 40.86
- ABUS 19.35
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.